advertisement

Topcon

Skrotzki F-E 1

Showing records 1 to 1 | Display all abstracts from Skrotzki F-E

11691 Two-year follow-up of latanoprost 0.005% monotherapy after changing from previous glaucoma therapies
Bayer A; Weiler W; Oeverhaus U; Skrotzki F-E; Stewart WC
Journal of Ocular Pharmacology and Therapeutics 2004; 20: 470-478

Issue 7-1

Change Issue


advertisement

Oculus